Apolipoprotein profile in type II diabetic patients with and without coronary heart disease
- PMID: 2087939
- DOI: 10.1007/BF02580943
Apolipoprotein profile in type II diabetic patients with and without coronary heart disease
Abstract
Diabetes mellitus is frequently associated with lipid metabolism abnormalities. In the present study the lipid and apolipoprotein profiles have been compared in type II diabetic subjects with (n = 30) and without (n = 30) coronary heart disease (CHD). All subjects were studied after good metabolic control had been achieved. Significant differences in plasma lipids and apolipoproteins were seen in diabetic patients with CHD in comparison with diabetics without CHD. Patients with CHD presented higher total cholesterol, triglyceride, LDL-cholesterol, apo B, apo CII and apo CIII levels and total cholesterol/HDL-cholesterol and LDL-cholesterol HDL-cholesterol ratios and lower HDL-cholesterol values and apo A1/apo B ratio than the patients without CHD. The same findings were found in females; while male subjects with CHD had significantly increased total cholesterol, LDL-cholesterol and apo B levels and total cholesterol/HDL-cholesterol and LDL-cholesterol/HDL-cholesterol ratios and significantly decreased apo A1/apo B ratio compared with males without CHD. These findings support the concept that the apolipoprotein profile plays a remarkable role as risk factor for CHD in type II diabetes mellitus.
Similar articles
-
Familial aggregation of non-insulin dependent diabetes and coronary heart disease are accompanied by different effects on serum lipids, lipoproteins and apolipoproteins.Atherosclerosis. 1991 Jan;86(1):17-29. doi: 10.1016/0021-9150(91)90095-k. Atherosclerosis. 1991. PMID: 2064632
-
Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.Clin Chim Acta. 2004 Jun;344(1-2):149-54. doi: 10.1016/j.cccn.2004.02.009. Clin Chim Acta. 2004. PMID: 15149883
-
Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.JAMA. 2007 Aug 15;298(7):776-85. doi: 10.1001/jama.298.7.776. JAMA. 2007. PMID: 17699011
-
Role of lipid and lipoprotein profiles in risk assessment and therapy.Am Heart J. 2003 Aug;146(2):227-33. doi: 10.1016/S0002-8703(02)94701-0. Am Heart J. 2003. PMID: 12891189 Review.
-
The contribution of lipids to coronary heart disease in diabetes mellitus.J Intern Med Suppl. 1994;736:41-6. J Intern Med Suppl. 1994. PMID: 7986307 Review.
Cited by
-
Correlation of serum alanine aminotransferase and aspartate aminotransferase with coronary heart disease.Int J Clin Exp Med. 2015 Mar 15;8(3):4399-404. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26064360 Free PMC article.
-
Identification of biomarker panels as predictors of severity in coronary artery disease.J Cell Mol Med. 2021 Feb;25(3):1518-1530. doi: 10.1111/jcmm.16244. Epub 2020 Dec 31. J Cell Mol Med. 2021. PMID: 33381894 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Medical